Twenty Fraction Prostate Radiotherapy with Intra-prostatic Boost: Results of a Pilot Study
Author:
Funder
Clatterbridge Cancer Charity
Publisher
Elsevier BV
Subject
Radiology Nuclear Medicine and imaging,Oncology
Reference35 articles.
1. Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials;Viani;Int J Radiat Oncol Biol Phys,2009
2. Long-term results of the Dutch randomized prostate cancer trial: impact of dose-escalation on local, biochemical, clinical failure, and survival;Heemsbergen;Radiother Oncol,2014
3. Risk of late toxicity in men receiving dose-escalated hypofractionated intensity modulated prostate radiation therapy: results from a randomized trial;Hoffman;Int J Radiat Oncol Biol Phys,2014
4. Intensity-modulated radiotherapy as primary therapy for prostate cancer: report on acute toxicity after dose escalation with simultaneous integrated boost to intraprostatic lesion;Fonteyne;Int J Radiat Oncol Biol Phys,2008
5. Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity;Ippolito;Am J Clin Oncol,2012
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Long-term Results of Hypofractionated Radiotherapy With Intra-prostatic Boosts in Men With Intermediate- and High-risk Prostate Cancer: A Phase II Trial;Clinical Oncology;2024-08
2. Dosimetric evaluation of ultrafractionated dose escalation with simultaneous integrated boost to intraprostatic lesion using 1.5-Tesla MR-Linac in localized prostate cancer;Reports of Practical Oncology and Radiotherapy;2024-02-16
3. Towards optimal heterogeneous prostate radiotherapy dose prescriptions based on patient‐specific or population‐based biological features;Medical Physics;2024-01-15
4. Effect of synthetic CT on dose-derived toxicity predictors for MR-only prostate radiotherapy;BJR|Open;2023-12-12
5. Proton versus photon therapy for high-risk prostate cancer with dose escalation of dominant intraprostatic lesions: a preliminary planning study;Frontiers in Oncology;2023-11-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3